Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.

Authors :: Lamb CA
Sebastian S
Kent AJ
Segal JP
Gonzalez HA
Brookes MJ
Mehta SJ
Subramanian S
Bhala N
Hicks LC
Conley TE
Patel KV
Walker GJ
Kennedy NA
Source :: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1236-1240.
Publication Year :: 2021

Subjects :: Cohort Studies
Humans
SARS-CoV-2
United Kingdom epidemiology
COVID-19
Inflammatory Bowel Diseases complications
Inflammatory Bowel Diseases drug therapy
Inflammatory Bowel Diseases epidemiology

Full Text Access

Tools